StockDocs
Main Newswire Learn
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
LEEE

Leef Brands Inc.

LEEEF OTC Medicinal Chemicals & Botanical Products EDGAR ↗
$0.18
-0.00 -1.09%

Key statistics

from XBRL data in SEC filings
Market cap ⓘ
$55.6M
Revenue (TTM) ⓘ
$34.8M
Net income (TTM) ⓘ
-$17.6M
EPS (TTM) ⓘ
$-0.10
P/E ratio ⓘ
—
Dividend yield ⓘ
—
Free cash flow ⓘ
-$979K
Cash ⓘ
$4.95M
Total assets ⓘ
$52.4M
Gross margin ⓘ
30.1%
52-week range ⓘ
$0.11 – $0.24

AI briefing

from the latest 10-K, 10-Q and 8-K events

Leef Brands is a California-based vertically integrated cannabis extraction and manufacturing company focused on B2B concentrate supply and, more recently, branded CPG sales.

What they do

Leef Brands operates a 12,000-square-foot extraction facility in California with three production lines: ethanol, hydrocarbon, and solventless extraction. The company sells bulk cannabis concentrates to brands in California and New York, and owns a 1,900-acre property in Santa Barbara County with a 179.9-acre cultivation permit. As of April 2026, it also sells branded consumer packaged goods (CPG) through the HIMALAYA brand following the acquisition of Standard Holdings.

Revenue drivers

  • Bulk B2B concentrate sales — Primary revenue stream; 2025 bulk concentrate-based sales (extracts, oils, vapors) to California and New York brands totaled $31.3 million.
  • CPG / HIMALAYA brand — New reportable segment starting Q2 2026 after acquisition of Standard Holdings; contributed $1,042,767 of net revenue in the six months ended June 30, 2026.
  • Cultivation (Salisbury Canyon Ranch) — Brings biomass supply in-house to reduce input costs and support concentrate margins; 57 acres planted in 2025, scaling to full 179.9 acres.

Recent performance

For the six months ended June 30, 2026, net revenue was $16.65 million, down from $18.09 million in the prior-year period. Gross margin expanded sharply to 42% from 20%, and operating loss narrowed to $0.70 million from $4.28 million. Net loss attributable to the company was $1.76 million, compared to $2.67 million in the prior-year period. Annual 2025 revenue was $34.8 million with a net loss of $17.6 million, and gross margin improved from 27% in 2024 to 30% in 2025, reaching 41% in H2 2025.

Strategy

The company is transitioning away from retail CPG sales—which were immaterial in fiscal 2025—to focus on high-margin wholesale concentrate manufacturing. It is scaling in-house cultivation at Salisbury Canyon Ranch to reduce input costs by an estimated 40–60% and improve gross margins. Management also plans to combine concentrate manufacturing with a growing branded CPG portfolio, following the HIMALAYA acquisition, while continuing to expand extraction capacity across all three lines.

Risks

  • Recurring net losses and need for capital — Net losses of $24.6M (2024) and $17.6M (2025); the company may need to raise additional capital, and profitability is not assured.
  • Negative equity — As of June 30, 2026, total liabilities exceeded total assets, with shareholder equity of negative $2.0 million.
  • Revenue decline — Quarterly revenue fell from $9.4M (Q1 2026) to $7.3M (Q2 2026), and six-month revenue declined year-over-year.
  • Regulatory and tax constraints — Section 280E limits expense deductions for cannabis companies, and market is subject to regulatory changes; unlicensed competition persists in California.

Outlook

Management expects full cultivated acreage to reach 179.9 acres by fall 2026, which should further reduce input costs and boost margins. The company anticipates that the combination of wholesale concentrate manufacturing and branded CPG will improve operating performance, despite ongoing market price compression. No explicit revenue or earnings guidance was provided.